Brain Cancer Research Investigator Grant

Funding Agency:

B*CURED’s primary goal is to fund innovative brain cancer research to end brain cancer. We invite clinical doctors and research scientists whose primary focus is brain cancer to apply for our grants.

Clinical and translational projects with significant clinical promise will be considered. Both adult and pediatric brain cancer projects will be considered.

Application Deadline: April 1, 2022

Agency Website

Eligibility Requirements

Applicants must be faculty at a research institution in North America who are:

• Undertaking clinical or translational research, with the intention of applying for R01 NIH funding or the equivalent within 5 years, or

• Undertaking innovative research to bridge from bench to animal research or to acquire preclinical data from animal models.

Applicants will compose an outstanding research proposal (5 pages maximum) that demonstrates relevance, sound methodological design, and feasibility. Formal involvement of a biostatistician is required for all clinical trial proposals, but is not required for pre-clinical or translational science proposals. 



Amount Description

The term of the grant is one year. The award will be for $50,000 and will be given in two installments. The first installment of $25,000 will be paid to the winner on or about June 30, 2022. The second installment of $25,000 will be paid after a satisfactory progress report (approximately 3 pages with a budget review) is submitted and approved by the B*CURED Medical Advisory Board. This progress report will be due exactly 6 months from the initial funding date. A final report (approximately 3 pages with a budget summary) is required from the grant winner exactly one year from the date of funding.

Funding Type





Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

April 1, 2022